Evidence map›Paper›PMID 37608527›Full record

ArticleJournal of hospital medicine2023

Barriers to initiate buprenorphine and methadone for opioid use disorder treatment with postdischarge treatment linkage.

Susan L Calcaterra, Steven Lockhart, Crystal Natvig, Susan Mikulich

Registry-linked trialAbstract read
In one paragraph

Article in Journal of hospital medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06291090 (In Hospital Treatment of Opioid Use Disorder), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06291090 nacompletednot on this map

In Hospital Treatment of Opioid Use Disorder: Clinician Perspectives and Current Practices

TypeinterventionalSponsorUniversity of Colorado, DenverRan2023 to 2025Enrolled400ConditionsOpioid Use DisorderArmsOUD treatment intervention
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Susan L CalcaterraDepartment of Medicine, Division of General Internal Medicine and Hospital Medicine, Univeristy of Colorado, Aurora, Colorado, USA.ORCID 0000-0002-0584-7783
Steven LockhartAdult and Child Center for Health Outcomes Research and Delivery Service, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
Crystal NatvigDepartment of Psychiatry, Univeristy of Colorado, Aurora, Colorado, USA.
Susan MikulichDepartment of Psychiatry, Univeristy of Colorado, Aurora, Colorado, USA.

Funding

Understanding Factors that Limit Access to Opioid Use Disorder Treatment in the Hospital to Inform Innovative Approaches to Expand Hospital-Based TreatmentK08DA049905 · NIDA · UNIVERSITY OF COLORADO DENVER · PI CALCATERRA, SUSAN L · 2020 to 2024
$945k
NIDA NIH HHS K08 DA049905NIDA NIH HHS K08DA049905
6 · The paper itself

Abstract

backgroundHospitals are an essential site of care for people with opioid use disorder (OUD). Buprenorphine and methadone are underutilized in the hospital.

objectivesCharacterize barriers to in-hospital buprenorphine or methadone initiation to inform implementation strategies to increase OUD treatment provision. DESIGN, SETTINGS, AND

participantsSurvey of hospital-based clinicians' perceptions of OUD treatment from 12 hospitals conducted between June 2022 and August 2022. MEASURES: Survey questions were grouped into six domains: (1) evidence to treat OUD, (2) hospital processes to treat OUD, (3) buprenorphine or methadone initiation, (4) clinical practices to treat OUD, (5) leadership prioritization of OUD treatment, and (6) job satisfaction. Likert responses were dichotomized and associations between "readiness" to initiate buprenorphine or methadone and each domain were assessed.

resultsOf 160 respondents (60% response rate), 72 (45%) reported higher readiness to initiate buprenorphine compared to methadone, 55 (34%). Respondents with higher readiness to initiate medications for OUD were more likely to perceive that evidence supports the use of buprenorphine and methadone to treat OUD (p < .001), to perceive fewer barriers to treat OUD (p < .001), to incorporate OUD treatment into their clinical practice (p < .001), to perceive leadership support for OUD treatment (p < .007), and to have great job satisfaction (p < .04). Clinicians reported that OUD treatment protocols with treatment linkage, increased education, and addiction specialist support would facilitate OUD treatment provision.

conclusionInterventions that incorporate protocols to initiate medications for OUD, include addiction specialist support and education, and ensure postdischarge OUD treatment linkage could facilitate hospital-based OUD treatment provision.

Indexed as

BuprenorphineOpioid-Related DisordersAftercareAnalgesics, OpioidHumansMethadoneOpiate Substitution TreatmentPatient DischargeAnalgesics, OpioidBuprenorphineMethadone

Identifiers

PMID37608527
PMCPMC10592161

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.